Company Filing History:
Years Active: 2016
Title: **Inventor Spotlight: Jon Sheperd**
Introduction
Jon Sheperd, hailing from Horsham, Great Britain, is an accomplished inventor known for his significant contributions to the pharmaceutical industry. With a keen focus on innovative solutions that address critical health challenges, Jon has paved the way for advancements in therapeutic applications.
Latest Patents
Jon Sheperd holds a patent for "Substituted pyrazino[1',2':1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel." This groundbreaking invention provides a compound of formula I or its pharmaceutically acceptable salts and outlines its therapeutic uses. Additionally, it offers a combination of pharmacologically active agents and a pharmaceutical composition aimed at enhancing treatment efficacy.
Career Highlights
Currently, Jon Sheperd is affiliated with Novartis AG, a leading global healthcare company dedicated to discovering and developing innovative medications. His work at Novartis involves extensive research and development that contributes to the advancement of novel therapies.
Collaborations
Throughout his career, Jon has collaborated with esteemed colleagues, including Mahbub Ahmed and Alexander Ashall-Kelly. These collaborations have fostered a creative and innovative environment, enabling the team to explore new frontiers in pharmaceutical research.
Conclusion
Jon Sheperd exemplifies the spirit of innovation within the pharmaceutical sector. His contributions, particularly through his patent, are a testament to his dedication to improving health outcomes. With continued collaboration and research, Jon is poised to make further impactful advancements in the field.